VBIO

Conviction 57HealthcareScan · Tue, Sep 8, 2026

Shooting star

VBIO$2.49-10.11%

ResistanceSupportVol 14

Vol MA14 11.75M

Jun 9Jun 26Jul 16Aug 3Aug 20Sep 8

Valion Bio, Inc.Pharmaceutical Preparationswww.tivichealth.com ↗

Price2.49

Change-10.11%

Gap-9.39%

Rel volume0.00×

Avg volume26.82M

Avg $ vol5.24M

SMA 201.01

SMA 500.6392

SMA 200—

Price vs 50+289.54%

Price vs 200—

MA stack—

50/200 cross—

Supertrendup · 2.01

RSI (14)69

MACD hist0.26

MACD crossbull · 9d

Stoch %K / %D63 / 69

ADX (14)61

+DI / −DI56 / 10

RSI divergenceBullish

MACD divergenceBullish

ATR %+14.95%

ADR %46.05%

52w high3.57

52w low0.1209

From 52w high-30.25%

Above 52w low+1959.55%

New 52w highNo

SqueezeOff

Bollinger width515.11%

%B0.79

Donchian pos63.28%

Donchian high3.87

Donchian low0.1116

AVWAP (52w high)3.17

vs AVWAP high-21.52%

AVWAP (52w low)0.1807

vs AVWAP low+1277.95%

OBV trendFlat

Chaikin MF (20)-0.40

Today vs 20d0.00×

Avg vol (14d)11.75M

Avg vol (20d)26.82M

Avg $ vol (20d)5.24M

Market cap55.25M

RS 3m (vs SPY)+260.05%

RS 6m (vs SPY)—

RS line new highNo

Trend template—

Technical rank86.9

1 week-30.25%

1 month+772.46%

3 months+225.49%

6 months—

1 year—

YTD+146.53%

P/E-6.22

P/B13.01

P/S—

P/FCF-7.85

EPS-19.68

Div yield—

ROE-209.09%

ROA-27.34%

Debt/Eq—

Current1.11

EV/EBITDA-6.73

Gross margin—

Net margin—

Rev growth—

EPS growth-56.99%

Price target—

Target upside—

Analyst rating—

Institutional2.25%

Ent. value53.14M

Revenue146K

Net income-7.1M

Gross profit-145K

Free cash flow-7.04M

IndustryPharmaceutical Preparations

ExchangeNasdaq

Shares out3.2M

Employees52

ListedThu, Nov 11, 2021

Free float3.09M

Float %98.5%

Short interest1.65M

Days to cover0.1d

Short volume53.3%

Squeeze score49 / 100

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeC

Conviction57 / 100

Pattern quality—

Tech rank86.9 / 100

Group rank—

Status lane—

Setup direction—

Pattern family

Resistance—

Support—

Days since event—

Candle confirmShooting star

News sentiment—

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in VBIO

All disclosures →

No recent disclosed trades by Congress in VBIO. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in VBIO · 3 buys · 2 sells

Insider	Side	Shares	Value	Traded	Filed
Wolf Lisa G Chief Financial Officer · Restricted Stock Units · 2026-06-18	Exercise	92	—	2026-06-18	2026-06-18
Wolf Lisa G Chief Financial Officer · Common Stock · 2026-06-18	Exercise	92	—	2026-06-18	2026-06-18
Handley Michael K Chief Executive Officer · Common Stock · 2026-05-18	Exercise	2.21K	—	2026-05-18	2026-05-20
Handley Michael K Chief Executive Officer · Restricted Stock Units · 2026-05-18	Exercise	2.21K	$0	2026-05-18	2026-05-20
Lackey Melinda General Counsel & SVP of Legal · Employee Stock Option (Right to Purchase) · 2026-05-01	Grant	45K	$0	2026-05-01	2026-05-04

SEC filings

EDGAR filings in VBIO · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.